Axon Enterprise (AXON) Financials

$731.72 +600.55 (+457.84%)

As of 05/23/2025 03:59 PM Eastern

Annual Income Statements for Axon Enterprise

This table shows Axon Enterprise's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	377	176	147	-60	-1.72	0.88	546	5.21	17	20
Consolidated Net Income / (Loss)	377	176	147	-60	-1.72	0.88	29	5.21	17	20
Net Income / (Loss) Continuing Operations	377	176	147	-60	-1.72	0.88	546	5.21	17	20
Total Pre-Tax Income	382	157	196	-141	-6.29	2.07	28	16	31	35
Total Operating Income	59	157	93	-168	-14	-6.39	25	13	32	35
Total Gross Profit	1,241	955	726	541	416	307	517	207	171	129
Total Revenue	2,083	1,561	1,187	863	681	531	840	344	268	198
Operating Revenue	2,083	1,561	1,187	863	681	531	840	344	268	198
Total Cost of Revenue	841	605	461	322	265	224	323	137	98	69
Operating Cost of Revenue	841	605	461	322	265	224	323	137	98	69
Total Operating Expenses	1,183	799	633	709	430	314	-25	194	139	93
Selling, General & Admin Expense	741	495	399	515	307	213	157	139	108	70
Research & Development Expense	442	304	234	194	123	101	77	55	31	24
Total Other Income / (Expense), net	323	0.21	103	27	7.86	8.46	3.26	2.74	-0.35	0.03
Interest & Investment Income	37	42	4.29	1.48	7.86	8.46	3.26	2.74	-0.35	0.03
Other Income / (Expense), net	286	-42	99	25	-	-	-	-	-	-
Income Tax Expense	4.47	-19	49	-81	-4.57	1.19	-1.10	11	14	15
Basic Earnings per Share	$4.98	$2.37	$2.07	($0.91)	($0.03)	$0.01	$0.52	$0.10	$0.33	$0.37
Weighted Average Basic Shares Outstanding	75.75M	74.20M	71.09M	66.19M	61.78M	59.19M	56.39M	52.73M	52.67M	53.55M
Diluted Earnings per Share	$4.80	$2.33	$2.03	($0.91)	($0.03)	$0.01	$0.50	$0.10	$0.32	$0.36
Weighted Average Diluted Shares Outstanding	78.56M	75.46M	72.53M	66.19M	61.78M	60.02M	57.92M	53.90M	53.54M	54.64M
Weighted Average Basic & Diluted Shares Outstanding	76.62M	75.30M	72.86M	70.93M	63.78M	59.53M	58.83M	52.10M	52.40M	53.90M

This table shows Axon Enterprise's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	88	136	67	41	133	57	61	12	45	29	12
Consolidated Net Income / (Loss)	88	136	67	41	133	57	61	12	45	29	12
Net Income / (Loss) Continuing Operations	88	136	67	41	133	57	61	12	45	29	12
Total Pre-Tax Income	108	86	80	51	166	56	72	-12	42	34	21
Total Operating Income	-8.79	-15	24	33	16	43	57	40	17	22	32
Total Gross Profit	366	347	331	304	260	263	257	232	204	203	193
Total Revenue	604	573	544	504	461	430	413	375	343	333	312
Operating Revenue	604	573	544	504	461	430	413	375	343	333	312
Total Cost of Revenue	238	227	214	200	201	167	157	142	139	130	118
Operating Cost of Revenue	238	227	214	200	201	167	157	142	139	130	118
Total Operating Expenses	375	362	307	271	244	220	199	192	187	181	161
Selling, General & Admin Expense	224	227	192	169	153	136	122	120	117	112	102
Research & Development Expense	151	135	114	101	91	84	77	72	71	69	59
Total Other Income / (Expense), net	117	100	55	18	149	13	14	-52	25	12	-11
Interest Expense	7.82	-	-	-	-	-	-	-	-	-	-
Interest & Investment Income	11	5.46	11	9.78	10	12	10	9.66	9.67	-87	-11
Other Income / (Expense), net	114	95	45	7.93	139	0.67	3.85	-62	16	-	-
Income Tax Expense	20	-50	13	9.79	33	-1.36	10	-25	-3.26	5.48	8.73
Basic Earnings per Share	$1.14	$1.78	$0.89	$0.54	$1.77	$0.76	$0.82	$0.17	$0.62	$0.41	$0.17
Weighted Average Basic Shares Outstanding	76.89M	75.75M	75.70M	75.51M	75.36M	74.20M	74.83M	74.22M	72.64M	71.09M	71.11M
Diluted Earnings per Share	$1.08	$1.68	$0.86	$0.53	$1.73	$0.75	$0.81	$0.16	$0.61	$0.39	$0.17
Weighted Average Diluted Shares Outstanding	81.48M	78.56M	78.08M	77.55M	77.13M	75.46M	75.95M	75.78M	73.88M	72.53M	72.53M
Weighted Average Basic & Diluted Shares Outstanding	77.85M	76.62M	76.25M	75.57M	75.47M	75.30M	74.93M	74.76M	73.89M	72.86M	71.17M

This table details how cash moves in and out of Axon Enterprise's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-134	245	-0.89	201	-17	-179	273	34	-16	11
Net Cash From Operating Activities	408	189	235	124	38	66	64	18	21	46
Net Cash From Continuing Operating Activities	408	189	235	124	38	66	64	18	21	46
Net Income / (Loss) Continuing Operations	377	176	147	-60	-1.72	0.88	29	5.21	17	20
Consolidated Net Income / (Loss)	377	176	147	-60	-1.72	0.88	29	5.21	17	20
Depreciation Expense	48	19	23	19	12	11	11	8.04	3.66	3.29
Non-Cash Adjustments To Reconcile Net Income	141	191	24	285	142	86	25	17	9.10	0.38
Changes in Operating Assets and Liabilities, net	-158	-197	41	-125	-117	-33	-1.42	-12	-10	21
Net Cash From Investing Activities	-491	12	-831	253	-357	-241	-9.86	19	-3.05	-36
Net Cash From Continuing Investing Activities	-491	12	-831	253	-357	-241	-9.86	19	-3.05	-36
Purchase of Property, Plant & Equipment	-79	-60	-56	-50	-73	-16	-11	-10	-4.96	-6.00
Acquisitions	-622	-21	-2.10	-23	-0.24	-0.40	-5.55	-12	-7.00	-12
Purchase of Investments	-793	-564	-845	-408	-664	-354	-4.33	-20	-56	-62
Sale and/or Maturity of Investments	1,003	657	72	733	380	130	11	61	65	44
Other Investing Activities, net	0.05	-0.54	-0.02	-	-	-	0.00	-	-	-
Net Cash From Financing Activities	-45	41	598	-174	299	-3.94	219	-3.82	-35	0.60
Net Cash From Continuing Financing Activities	-45	41	598	-174	299	-3.94	219	-3.82	-35	0.60
Repayment of Debt	-1.84	0.00	0.00	-	-	-	-	-	-	-0.08
Issuance of Debt	0.00	0.00	674	0.00	0.00	-	-	-	-	-
Issuance of Common Equity	0.00	0.00	124	0.00	0.00	0.00	234	0.00	0.00	-
Other Financing Activities, net	-44	41	-200	-174	299	-3.94	-15	-3.82	-0.81	8.24
Effect of Exchange Rate Changes	-6.21	2.07	-3.38	-1.98	1.98	0.33	-	-	0.91	0.12
Cash Interest Paid	3.45	3.51	0.00	-	-	-	-	-	-	-
Cash Income Taxes Paid	68	64	11	-	-	-	-	-	-	-

This table details how cash moves in and out of Axon Enterprise's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	638	-231	129	163	-195	193	-68	211	-90	206	-65
Net Cash From Operating Activities	26	250	91	83	-16	140	63	43	-56	131	41
Net Cash From Continuing Operating Activities	26	250	91	83	-16	140	63	43	-56	131	41
Net Income / (Loss) Continuing Operations	88	135	68	41	133	57	61	12	45	29	12
Consolidated Net Income / (Loss)	88	135	68	41	133	57	61	12	45	29	12
Depreciation Expense	19	18	6.18	13	12	6.47	-1.33	7.48	6.69	4.95	6.21
Non-Cash Adjustments To Reconcile Net Income	38	54	76	73	-62	40	32	98	22	31	43
Changes in Operating Assets and Liabilities, net	-120	43	-65	-41	-95	37	-35	-72	-127	66	-20
Net Cash From Investing Activities	-702	-442	43	82	-174	53	-122	154	-73	-529	-103
Net Cash From Continuing Investing Activities	-702	-442	43	82	-174	53	-122	154	-73	-529	-103
Purchase of Property, Plant & Equipment	-25	-25	-26	-11	-16	-24	-14	-13	-8.51	-12	-14
Acquisitions	0.00	-384	-	-0.03	-238	-	0.12	-21	-0.13	0.19	-0.09
Purchase of Investments	-1,079	-178	-124	-240	-251	-119	-188	-112	-145	-574	-95
Sale and/or Maturity of Investments	402	145	194	334	330	196	80	300	81	57	6.01
Other Investing Activities, net	0.00	0.02	-	-	-	-0.03	-	-	-	-	-
Net Cash From Financing Activities	1,313	-33	-7.71	-2.19	-2.71	-3.82	-7.12	14	38	601	-0.07
Net Cash From Continuing Financing Activities	1,313	-33	-7.71	-2.19	-2.71	-3.82	-7.12	14	38	601	-0.07
Repayment of Debt	-432	-	-	-	-	-	-	-	-	-	-
Issuance of Debt	1,750	-	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	-5.04	-31	-7.71	-2.19	-2.71	91	-102	14	38	-197	-0.07
Effect of Exchange Rate Changes	1.19	-	-	-0.11	-1.98	3.27	-2.01	0.03	0.78	3.40	-2.87
Cash Interest Paid	0.50	-	-	-	-	-	-	-	-	-	-
Cash Income Taxes Paid	0.05	-	-	-	-	-	-	-	-	-	-

This table presents Axon Enterprise's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	4,475	3,409	2,852	1,688	1,381	846	720	338	278	230
Total Current Assets	2,297	2,394	1,805	1,109	982	609	558	205	177	161
Cash & Equivalents	455	599	354	356	155	172	349	75	41	60
Short-Term Investments	532	722	621	87	407	179	0.00	6.86	48	50
Note & Lease Receivable	548	413	358	321	229	147	131	56	39	28
Inventories, net	265	270	202	109	90	39	34	45	35	16
Prepaid Expenses	130	103	73	57	37	35	30	22	14	8.17
Other Current Assets	368	287	197	180	64	38	-	0.00	-	-
Plant, Property, & Equipment, net	247	201	170	138	105	44	38	31	24	22
Total Noncurrent Assets	1,930	815	877	440	294	192	123	102	77	47
Long-Term Investments	333	232	156	31	102	45	0.00	-	0.23	8.53
Noncurrent Note & Lease Receivables	3.46	2.59	5.21	11	22	32	40	37	18	1.23
Goodwill	757	58	45	44	25	25	25	15	10	9.60
Intangible Assets	175	20	12	15	9.45	13	16	19	15	7.59
Noncurrent Deferred & Refundable Income Taxes	304	228	157	127	46	28	19	16	20	14
Other Noncurrent Operating Assets	357	275	205	128	88	50	23	15	14	5.97
Total Liabilities & Shareholders' Equity	4,475	3,409	2,852	1,688	1,381	846	720	338	278	230
Total Liabilities	2,147	1,793	1,583	640	405	302	252	171	127	73
Total Current Liabilities	998	762	603	419	256	196	166	108	78	38
Accounts Payable	72	66	60	32	24	26	15	8.59	11	7.33
Accrued Expenses	279	194	156	104	60	45	41	24	18	8.64
Customer Deposits	21	22	20	10	2.96	-	-	-	2.15	1.23
Current Deferred Revenue	613	470	360	266	164	118	107	70	45	21
Other Current Liabilities	13	9.79	6.36	6.54	5.43	6.83	2.74	3.76	0.08	0.09
Total Noncurrent Liabilities	1,149	1,032	981	222	148	107	86	63	49	35
Long-Term Debt	680	677	674	-	-	-	-	-	-	-
Noncurrent Deferred Revenue	361	271	248	186	111	88	-	55	40	30
Noncurrent Deferred & Payable Income Tax Liabilities	25	18	11	4.61	5.15	4.19	2.85	1.71	1.90	1.32
Noncurrent Employee Benefit Liabilities	16	11	6.29	5.68	4.73	3.94	3.24	3.86	3.36	2.20
Other Noncurrent Operating Liabilities	67	54	42	26	27	11	80	2.27	3.92	1.03
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,328	1,616	1,268	1,048	976	543	467	167	151	157
Total Preferred & Common Equity	2,328	1,616	1,268	1,048	976	543	467	167	151	157
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,328	1,616	1,268	1,048	976	543	467	167	151	157
Common Stock	1,690	1,347	1,175	1,095	962	528	453	202	188	178
Retained Earnings	812	435	257	110	170	172	171	123	118	101
Treasury Stock	-156	-156	-156	-156	-156	-156	-156	-156	-156	-122
Accumulated Other Comprehensive Income / (Loss)	-18	-11	-7.18	-1.32	0.14	-1.10	-1.51	-1.47	0.90	0.08

This table presents Axon Enterprise's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	6,083	4,475	4,006	3,742	3,616	3,409	3,254	3,077	3,008	2,852	2,010
Total Current Assets	3,777	2,297	2,434	2,206	2,202	2,394	2,258	2,113	2,053	1,805	1,206
Cash & Equivalents	1,093	455	695	566	404	599	406	474	263	354	148
Short-Term Investments	1,274	532	463	510	660	722	785	660	830	621	230
Note & Lease Receivable	600	548	513	386	477	413	443	372	380	358	418
Inventories, net	280	265	272	278	271	270	260	250	220	202	173
Prepaid Expenses	156	130	118	122	124	103	104	102	142	73	68
Other Current Assets	374	368	373	343	266	287	261	255	217	197	169
Plant, Property, & Equipment, net	260	247	236	215	209	201	187	179	173	170	164
Total Noncurrent Assets	2,047	1,930	1,336	1,321	1,205	815	809	786	783	877	641
Long-Term Investments	414	333	388	363	295	232	0.00	15	31	156	29
Noncurrent Note & Lease Receivables	3.32	3.46	2.90	3.04	2.40	2.59	4.38	5.28	4.47	5.21	8.46
Goodwill	756	757	308	308	308	58	57	58	45	45	45
Intangible Assets	169	175	82	86	89	20	20	22	11	12	13
Noncurrent Deferred & Refundable Income Taxes	336	304	244	227	209	228	214	199	171	157	96
Other Noncurrent Operating Assets	369	357	311	335	301	275	273	253	223	205	159
Total Liabilities & Shareholders' Equity	6,083	4,475	4,006	3,742	3,616	3,409	3,254	3,077	3,008	2,852	2,010
Total Liabilities	3,527	2,147	1,906	1,814	1,798	1,793	1,733	1,632	1,605	1,583	779
Total Current Liabilities	1,337	998	823	766	757	762	718	625	616	603	432
Short-Term Debt	279	-	-	-	-	-	-	-	-	-	-
Accounts Payable	98	72	76	104	82	66	90	73	66	60	50
Accrued Expenses	267	279	210	142	127	194	147	118	121	156	113
Customer Deposits	22	21	22	23	22	22	16	15	14	20	15
Current Deferred Revenue	661	613	505	486	516	470	455	412	408	360	246
Other Current Liabilities	11	13	11	12	9.60	9.79	9.49	7.36	7.51	6.36	6.80
Total Noncurrent Liabilities	2,191	1,149	1,083	1,047	1,041	1,032	1,015	1,007	989	981	348
Long-Term Debt	1,728	680	679	679	678	677	676	676	675	674	-
Noncurrent Deferred Revenue	349	361	305	291	294	271	270	265	250	248	314
Noncurrent Deferred & Payable Income Tax Liabilities	29	25	20	19	19	18	21	21	16	11	7.32
Noncurrent Employee Benefit Liabilities	19	16	16	14	15	11	9.15	8.77	7.98	6.29	5.37
Other Noncurrent Operating Liabilities	67	67	62	44	36	54	38	37	40	42	21
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,556	2,328	2,100	1,929	1,818	1,616	1,521	1,445	1,403	1,268	1,231
Total Preferred & Common Equity	2,556	2,328	2,100	1,929	1,818	1,616	1,521	1,445	1,403	1,268	1,231
Preferred Stock	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,556	2,328	2,100	1,929	1,818	1,616	1,521	1,445	1,403	1,268	1,231
Common Stock	1,830	1,690	1,588	1,494	1,421	1,347	1,316	1,293	1,262	1,175	1,167
Retained Earnings	900	812	677	605	564	435	374	315	302	257	228
Treasury Stock	-156	-156	-156	-156	-156	-156	-156	-156	-156	-156	-156
Accumulated Other Comprehensive Income / (Loss)	-18	-18	-9.12	-14	-12	-11	-13	-6.73	-5.32	-7.18	-7.81

This table displays calculated financial ratios and metrics derived from Axon Enterprise's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	33.44%	31.47%	37.50%	26.78%	28.28%	-36.81%	144.37%	28.17%	35.55%	20.28%
EBITDA Growth	192.96%	-37.57%	280.80%	-7,222.57%	-68.66%	-84.97%	68.33%	-42.72%	-8.70%	6.61%
EBIT Growth	200.05%	-40.11%	234.36%	-909.60%	-121.30%	-125.74%	90.75%	-59.11%	-9.86%	8.71%
NOPAT Growth	-67.04%	152.18%	159.15%	-1,088.15%	-263.57%	-110.55%	499.99%	-75.40%	-12.18%	-0.60%
Net Income Growth	114.49%	19.64%	344.81%	-3,381.32%	-295.46%	-96.98%	460.88%	-69.90%	-13.22%	0.08%
EPS Growth	106.01%	14.78%	323.08%	-2,933.33%	-400.00%	-98.00%	400.00%	-68.75%	-11.11%	-2.70%
Operating Cash Flow Growth	115.74%	-19.59%	89.05%	223.52%	-41.41%	2.81%	245.81%	-12.60%	-54.49%	31.08%
Free Cash Flow Firm Growth	-1,678.79%	-212.03%	115.11%	-69.46%	-444.33%	57.84%	-247.41%	828.21%	-135.52%	-24.29%
Invested Capital Growth	128.06%	43.81%	5.08%	57.13%	111.87%	24.90%	638.11%	-74.77%	63.51%	-0.10%
Revenue Q/Q Growth	7.26%	6.38%	10.81%	19.12%	28.33%	-53.31%	110.07%	3.80%	10.75%	4.89%
EBITDA Q/Q Growth	10.35%	-13.87%	217.94%	-6.00%	107.52%	-74.10%	-13.70%	-5.36%	2.01%	-0.66%
EBIT Q/Q Growth	12.75%	-15.99%	339.77%	-5.60%	58.76%	-164.04%	-18.54%	-11.94%	2.92%	-1.16%
NOPAT Q/Q Growth	-40.04%	18.06%	90.21%	-24.28%	58.76%	-130.20%	8.66%	-61.09%	7.34%	-0.24%
Net Income Q/Q Growth	27.20%	18.74%	40.66%	-190.28%	95.68%	-94.25%	16.58%	-61.77%	7.70%	0.10%
EPS Q/Q Growth	24.68%	18.27%	32.68%	-139.47%	95.45%	-95.65%	11.11%	-61.54%	10.34%	-2.70%
Operating Cash Flow Q/Q Growth	36.93%	4.95%	100.87%	-14.66%	-22.99%	28.51%	12.14%	376.72%	-44.51%	7.74%
Free Cash Flow Firm Q/Q Growth	-140.64%	39.70%	165.97%	-14.87%	-39.32%	-113.40%	-611.21%	193.54%	-135.79%	5.15%
Invested Capital Q/Q Growth	36.97%	-3.38%	-3.71%	13.84%	16.54%	-11.49%	-17.16%	-85.19%	52.15%	-14.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	59.61%	61.22%	61.16%	62.65%	61.14%	57.88%	61.56%	60.24%	63.57%	65.01%
EBITDA Margin	18.89%	8.60%	18.12%	-13.78%	0.25%	1.00%	4.22%	6.13%	13.71%	20.35%
Operating Margin	2.81%	10.05%	7.83%	-19.47%	-2.08%	-1.20%	2.96%	3.79%	11.87%	17.86%
EBIT Margin	16.56%	7.37%	16.17%	-16.55%	-2.08%	-1.20%	2.96%	3.79%	11.87%	17.86%
Profit (Net Income) Margin	18.10%	11.26%	12.38%	-6.95%	-0.25%	0.17%	3.48%	1.51%	6.45%	10.07%
Tax Burden Percent	98.83%	111.92%	74.87%	42.45%	27.40%	42.61%	103.92%	33.04%	54.92%	56.37%
Interest Burden Percent	110.61%	136.64%	102.24%	98.96%	44.46%	-32.37%	113.14%	121.02%	98.89%	100.07%
Effective Tax Rate	1.17%	-11.92%	25.13%	0.00%	0.00%	57.39%	-3.92%	66.96%	45.08%	43.63%
Return on Invested Capital (ROIC)	4.76%	27.96%	13.85%	-29.35%	-4.31%	-2.06%	38.58%	10.86%	34.30%	51.45%
ROIC Less NNEP Spread (ROIC-NNEP)	-37.41%	27.93%	2.06%	-38.79%	-5.86%	-3.02%	37.15%	10.01%	34.49%	51.43%
Return on Net Nonoperating Assets (RNNOA)	14.36%	-15.77%	-1.17%	23.42%	4.09%	2.23%	-28.99%	-7.31%	-23.07%	-37.51%
Return on Equity (ROE)	19.12%	12.19%	12.69%	-5.93%	-0.23%	0.17%	9.58%	3.55%	11.24%	13.93%
Cash Return on Invested Capital (CROIC)	-73.31%	-7.98%	8.89%	-73.78%	-76.06%	-24.20%	-113.70%	130.26%	-13.90%	51.54%
Operating Return on Assets (OROA)	8.75%	3.67%	8.46%	-9.31%	-1.27%	-0.82%	5.59%	5.82%	12.54%	17.02%
Return on Assets (ROA)	9.56%	5.62%	6.47%	-3.91%	-0.15%	0.11%	6.57%	2.33%	6.81%	9.60%
Return on Common Equity (ROCE)	19.12%	12.19%	12.69%	-5.93%	-0.23%	0.17%	9.58%	3.55%	11.24%	13.93%
Return on Equity Simple (ROE_SIMPLE)	16.20%	10.88%	11.58%	-5.73%	-0.18%	0.16%	6.25%	3.66%	11.46%	12.70%
Net Operating Profit after Tax (NOPAT)	58	176	70	-118	-9.91	-2.72	26	4.30	17	20
NOPAT Margin	2.78%	11.25%	5.86%	-13.63%	-1.45%	-0.51%	3.07%	1.25%	6.52%	10.07%
Net Nonoperating Expense Percent (NNEP)	42.17%	0.03%	11.79%	9.44%	1.54%	0.97%	1.43%	0.85%	-0.19%	0.01%
Return On Investment Capital (ROIC_SIMPLE)	1.92%	7.66%	3.58%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	40.39%	38.78%	38.84%	37.35%	38.87%	42.12%	38.44%	39.76%	36.57%	34.99%
SG&A Expenses to Revenue	35.59%	31.71%	33.64%	59.65%	45.12%	40.12%	18.67%	40.34%	40.29%	35.22%
R&D to Revenue	21.20%	19.46%	19.70%	22.47%	18.09%	18.97%	9.15%	16.11%	11.41%	11.93%
Operating Expenses to Revenue	56.80%	51.17%	53.33%	82.12%	63.21%	59.09%	-2.96%	56.45%	51.70%	47.15%
Earnings before Interest and Taxes (EBIT)	345	115	192	-143	-14	-6.39	25	13	32	35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	393	134	215	-119	1.67	5.33	35	21	37	40
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	18.60	11.65	9.31	10.26	7.98	8.00	5.47	9.86	8.40	5.91
Price to Tangible Book Value (P/TBV)	31.03	12.24	9.75	10.87	8.27	8.60	6.00	9.86	10.12	6.63
Price to Revenue (P/Rev)	20.79	12.06	9.95	12.45	11.43	8.19	3.04	4.08	4.72	4.69
Price to Earnings (P/E)	114.85	107.08	80.37	0.00	0.00	4,930.28	4.68	269.29	73.27	46.53
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.87%	0.93%	1.24%	0.00%	0.00%	0.02%	21.37%	0.37%	1.36%	2.15%
Enterprise Value to Invested Capital (EV/IC)	25.26	24.23	22.04	20.97	22.84	26.85	18.73	87.81	18.64	20.91
Enterprise Value to Revenue (EV/Rev)	20.49	11.50	9.56	11.90	10.46	7.44	2.63	4.08	4.40	4.09
Enterprise Value to EBITDA (EV/EBITDA)	108.47	133.67	52.78	0.00	4,264.92	741.78	62.26	66.57	32.08	20.09
Enterprise Value to EBIT (EV/EBIT)	123.70	156.13	59.14	0.00	0.00	0.00	88.87	107.67	37.04	22.90
Enterprise Value to NOPAT (EV/NOPAT)	737.46	102.24	163.07	0.00	0.00	0.00	85.52	325.91	67.44	40.62
Enterprise Value to Operating Cash Flow (EV/OCF)	104.49	94.83	48.23	82.54	185.09	60.18	34.56	75.91	55.82	17.42
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	253.99	0.00	0.00	0.00	0.00	27.17	0.00	40.55
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.29	0.42	0.53	0.00	0.00	0.00	0.00	0.00	0.01	0.00
Long-Term Debt to Equity	0.29	0.42	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.38	-0.56	-0.57	-0.60	-0.70	-0.74	-0.78	-0.73	-0.67	-0.73
Leverage Ratio	2.00	2.17	1.96	1.52	1.47	1.55	1.46	1.53	1.65	1.45
Compound Leverage Factor	2.21	2.97	2.00	1.50	0.65	-0.50	1.65	1.85	1.63	1.45
Debt to Total Capital	22.62%	29.53%	34.70%	0.00%	0.00%	0.00%	0.00%	0.00%	1.11%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.11%	0.00%
Long-Term Debt to Total Capital	22.62%	29.53%	34.70%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	77.38%	70.47%	65.30%	100.00%	100.00%	100.00%	100.00%	100.00%	98.89%	100.00%
Debt to EBITDA	1.73	5.04	3.13	0.00	0.00	0.00	0.00	0.00	0.05	0.00
Net Debt to EBITDA	-1.62	-6.52	-2.12	0.00	0.00	0.00	0.00	0.00	-2.38	0.00
Long-Term Debt to EBITDA	1.73	5.04	3.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	11.76	3.86	9.68	0.00	0.00	0.00	0.00	0.00	0.10	0.00
Net Debt to NOPAT	-11.04	-4.99	-6.56	0.00	0.00	0.00	0.00	0.00	-5.01	0.00
Long-Term Debt to NOPAT	11.76	3.86	9.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	13.42	7.62	5.75	10.89	12.80	10.11	8.35	9.06	8.34	10.26
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.30	3.14	3.00	2.65	3.83	3.12	3.36	1.17	2.27	4.23
Quick Ratio	1.54	2.28	2.21	1.83	3.09	2.54	2.98	0.87	1.65	3.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-891	-50	45	-296	-175	-32	-76	52	-7.09	20
Operating Cash Flow to CapEx	518.26%	317.37%	421.78%	249.77%	53.05%	412.03%	573.44%	177.69%	430.01%	778.89%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.50	0.52	0.56	0.61	0.68	1.89	1.54	1.06	0.95
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	3.14	2.56	2.96	3.25	4.11	6.16	0.00	0.00	3.88	4.06
Fixed Asset Turnover	9.30	8.43	7.70	7.08	9.12	13.00	0.00	0.00	11.70	10.05
Accounts Payable Turnover	12.21	9.62	10.01	11.44	10.58	10.90	0.00	0.00	10.86	9.22
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	116.11	142.42	123.17	112.42	88.81	59.27	0.00	0.00	94.13	89.84
Days Payable Outstanding (DPO)	29.90	37.92	36.47	31.90	34.49	33.50	0.00	0.00	33.61	39.57
Cash Conversion Cycle (CCC)	86.21	104.50	86.70	80.52	54.33	25.77	0.00	0.00	60.52	50.26
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,689	741	515	490	312	147	118	16	63	39
Invested Capital Turnover	1.71	2.49	2.36	2.15	2.97	4.01	12.56	8.68	5.26	5.11
Increase / (Decrease) in Invested Capital	948	226	25	178	165	29	102	-47	25	-0.04
Enterprise Value (EV)	42,665	17,947	11,352	10,275	7,122	3,952	2,208	1,402	1,180	809
Market Capitalization	43,303	18,822	11,808	10,749	7,787	4,349	2,557	1,402	1,267	927
Book Value per Share	$30.52	$21.56	$17.82	$15.30	$15.36	$9.16	$8.00	$2.69	$2.89	$2.93
Tangible Book Value per Share	$18.30	$20.53	$17.02	$14.44	$14.82	$8.52	$7.30	$2.69	$2.40	$2.61
Total Capital	3,008	2,293	1,942	1,048	976	543	467	142	153	157
Total Debt	680	677	674	0.00	0.00	0.00	0.00	0.00	1.69	0.00
Total Long-Term Debt	680	677	674	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-639	-875	-457	-474	-664	-396	-349	0.00	-88	-118
Capital Expenditures (CapEx)	79	60	56	50	73	16	11	10	4.92	5.96
Debt-free, Cash-free Net Working Capital (DFCFNWC)	314	312	228	248	164	63	43	17	12	13
Debt-free Net Working Capital (DFNWC)	1,300	1,632	1,203	691	726	414	392	17	101	123
Net Working Capital (NWC)	1,300	1,632	1,203	691	726	414	392	17	99	123
Net Nonoperating Expense (NNE)	-319	-0.24	-77	-58	-8.18	-3.61	-3.39	-0.90	0.19	-0.01
Net Nonoperating Obligations (NNO)	-639	-875	-753	-558	-664	-396	-349	-126	-88	-118
Total Depreciation and Amortization (D&A)	48	19	23	24	16	12	11	8.04	4.92	4.94
Debt-free, Cash-free Net Working Capital to Revenue	15.06%	19.96%	19.20%	28.72%	24.03%	11.89%	5.08%	4.92%	4.40%	6.82%
Debt-free Net Working Capital to Revenue	62.42%	104.58%	101.30%	80.03%	106.55%	77.97%	46.68%	4.92%	37.61%	62.29%
Net Working Capital to Revenue	62.42%	104.58%	101.30%	80.03%	106.55%	77.97%	46.68%	4.92%	36.98%	62.29%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.98	$2.35	$2.07	($0.91)	($0.03)	$0.01	$0.52	$0.10	$0.33	$0.37
Adjusted Weighted Average Basic Shares Outstanding	75.75M	74.20M	71.09M	66.19M	61.78M	59.19M	56.39M	52.73M	52.67M	53.55M
Adjusted Diluted Earnings per Share	$4.80	$2.31	$2.03	($0.91)	($0.03)	$0.01	$0.50	$0.10	$0.32	$0.36
Adjusted Weighted Average Diluted Shares Outstanding	78.56M	75.46M	72.53M	66.19M	61.78M	60.02M	57.92M	53.90M	53.54M	54.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	76.62M	75.30M	72.86M	70.93M	63.78M	59.53M	58.83M	53.03M	52.33M	53.69M
Normalized Net Operating Profit after Tax (NOPAT)	58	110	70	-118	-9.91	-4.48	17	9.12	17	20
Normalized NOPAT Margin	2.78%	7.04%	5.86%	-13.63%	-1.45%	-0.84%	2.07%	2.65%	6.52%	10.07%
Pre Tax Income Margin	18.32%	10.06%	16.53%	-16.37%	-0.92%	0.39%	3.35%	4.58%	11.74%	17.87%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	195.10%	37.91%

This table displays calculated financial ratios and metrics derived from Axon Enterprise's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	31.26%	33.42%	31.70%	34.57%	34.31%	28.93%	32.57%	31.16%	33.78%	53.21%	34.38%
EBITDA Growth	-23.22%	96.86%	24.73%	389.84%	354.82%	82.69%	57.96%	-163.62%	54.81%	228.45%	311.44%
EBIT Growth	-32.09%	85.43%	11.95%	287.43%	382.17%	94.21%	90.83%	-201.69%	87.38%	182.25%	1,010.97%
NOPAT Growth	-153.96%	-153.53%	-58.67%	-5.93%	-26.88%	132.96%	162.82%	76.75%	37.53%	198.79%	823.06%
Net Income Growth	-34.02%	138.94%	9.32%	228.48%	195.13%	96.49%	405.39%	-75.63%	-17.74%	314.44%	-75.00%
EPS Growth	-37.57%	124.00%	6.17%	231.25%	183.61%	92.31%	376.47%	-77.46%	-19.74%	454.55%	-74.63%
Operating Cash Flow Growth	261.84%	78.64%	45.20%	94.02%	71.70%	6.80%	53.77%	120.15%	-228.11%	914.08%	148.65%
Free Cash Flow Firm Growth	-39.77%	-433.92%	-144.35%	-102.52%	-210.88%	-2,834.38%	-113.18%	-25.75%	-8.17%	96.85%	46.73%
Invested Capital Growth	56.76%	128.06%	60.87%	58.37%	73.09%	43.81%	43.33%	44.65%	34.40%	5.08%	24.24%
Revenue Q/Q Growth	5.27%	5.35%	7.97%	9.41%	6.62%	3.99%	10.32%	9.20%	2.05%	6.93%	9.15%
EBITDA Q/Q Growth	27.82%	30.86%	46.06%	-68.54%	230.16%	-17.09%	439.39%	-149.38%	29.86%	-28.31%	36.70%
EBIT Q/Q Growth	31.74%	16.87%	68.08%	-73.73%	262.88%	-29.44%	381.42%	-167.58%	42.93%	-30.67%	49.96%
NOPAT Q/Q Growth	69.42%	-215.06%	-23.48%	102.57%	-70.21%	-11.15%	74.15%	57.45%	-5.48%	0.24%	17.12%
Net Income Q/Q Growth	-35.31%	102.90%	64.29%	-69.38%	132.61%	-7.17%	393.63%	-72.49%	54.72%	138.78%	-76.20%
EPS Q/Q Growth	-35.71%	95.35%	62.26%	-69.36%	127.63%	-7.41%	406.25%	-73.77%	56.41%	129.41%	-76.06%
Operating Cash Flow Q/Q Growth	-89.69%	173.94%	10.34%	619.28%	-111.38%	122.66%	47.44%	175.73%	-142.96%	220.58%	111.09%
Free Cash Flow Firm Q/Q Growth	32.87%	-117.74%	-10.48%	13.48%	-162.36%	0.35%	8.43%	-32.82%	-2,409.42%	92.76%	45.99%
Invested Capital Q/Q Growth	5.49%	36.97%	5.59%	2.75%	54.25%	-3.38%	3.95%	12.30%	27.51%	-3.71%	4.91%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.59%	60.49%	60.77%	60.25%	56.44%	61.10%	62.10%	61.96%	59.50%	60.94%	61.99%
EBITDA Margin	20.72%	17.06%	13.74%	10.16%	35.31%	11.56%	14.51%	-4.72%	10.43%	8.16%	12.17%
Operating Margin	-1.46%	-2.56%	4.42%	6.52%	3.53%	9.90%	13.89%	10.75%	4.84%	6.68%	10.30%
EBIT Margin	17.50%	13.98%	12.60%	8.10%	33.72%	10.06%	14.83%	-5.81%	9.39%	6.68%	10.30%
Profit (Net Income) Margin	14.58%	23.72%	12.31%	8.09%	28.91%	13.24%	14.83%	3.32%	13.16%	8.69%	3.89%
Tax Burden Percent	81.17%	158.83%	84.24%	80.64%	80.39%	102.44%	85.47%	-102.57%	107.77%	84.08%	58.16%
Interest Burden Percent	102.64%	106.81%	116.01%	123.97%	106.68%	128.51%	117.07%	55.62%	130.00%	154.76%	64.96%
Effective Tax Rate	18.83%	-58.83%	15.76%	19.36%	19.61%	-2.44%	14.53%	0.00%	-7.77%	15.92%	41.84%
Return on Invested Capital (ROIC)	-1.80%	-6.98%	7.24%	9.99%	5.33%	25.22%	26.77%	16.47%	11.63%	13.26%	13.30%
ROIC Less NNEP Spread (ROIC-NNEP)	-14.87%	-28.03%	1.47%	8.05%	-11.50%	23.59%	25.09%	18.74%	7.69%	11.70%	14.24%
Return on Net Nonoperating Assets (RNNOA)	4.95%	10.76%	-0.66%	-3.50%	5.10%	-13.32%	-13.23%	-9.88%	-4.21%	-6.62%	-8.38%
Return on Equity (ROE)	3.15%	3.78%	6.58%	6.49%	10.42%	11.90%	13.55%	6.59%	7.43%	6.64%	4.91%
Cash Return on Invested Capital (CROIC)	-41.88%	-73.31%	-37.02%	-32.04%	-37.32%	-7.98%	-12.76%	-15.79%	-15.95%	8.89%	-14.04%
Operating Return on Assets (OROA)	8.03%	7.39%	6.74%	4.30%	17.11%	5.02%	8.26%	-3.17%	5.02%	3.49%	6.04%
Return on Assets (ROA)	6.69%	12.53%	6.59%	4.30%	14.68%	6.60%	8.27%	1.81%	7.03%	4.54%	2.28%
Return on Common Equity (ROCE)	3.15%	3.78%	6.58%	6.49%	10.42%	11.90%	13.55%	6.59%	7.43%	6.64%	4.91%
Return on Equity Simple (ROE_SIMPLE)	12.98%	0.00%	14.12%	15.07%	14.43%	0.00%	9.73%	6.84%	9.79%	0.00%	8.48%
Net Operating Profit after Tax (NOPAT)	-7.14	-23	20	27	13	44	49	28	18	19	19
NOPAT Margin	-1.18%	-4.07%	3.73%	5.26%	2.84%	10.15%	11.88%	7.52%	5.22%	5.61%	5.99%
Net Nonoperating Expense Percent (NNEP)	13.07%	21.05%	5.77%	1.95%	16.83%	1.63%	1.69%	-2.27%	3.94%	1.56%	-0.95%
Return On Investment Capital (ROIC_SIMPLE)	-0.16%	-0.78%	-	-	-	1.90%	-	-	-	0.96%	-
Cost of Revenue to Revenue	39.41%	39.51%	39.23%	39.75%	43.56%	38.90%	37.90%	38.04%	40.50%	39.06%	38.01%
SG&A Expenses to Revenue	37.03%	39.58%	35.31%	33.61%	33.14%	31.65%	29.61%	32.01%	33.98%	33.65%	32.73%
R&D to Revenue	25.02%	23.47%	21.03%	20.12%	19.77%	19.54%	18.60%	19.20%	20.68%	20.62%	18.97%
Operating Expenses to Revenue	62.05%	63.05%	56.34%	53.73%	52.91%	51.19%	48.21%	51.22%	54.66%	54.27%	51.69%
Earnings before Interest and Taxes (EBIT)	106	80	69	41	155	43	61	-22	32	22	32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	125	98	75	51	163	50	60	-18	36	27	38
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	14.99	18.60	13.87	11.12	12.54	11.65	9.53	9.84	11.68	9.31	6.68
Price to Tangible Book Value (P/TBV)	23.49	31.03	17.03	13.96	16.05	12.24	10.04	10.41	12.17	9.75	7.01
Price to Revenue (P/Rev)	17.21	20.79	15.00	11.84	13.56	12.06	9.88	10.41	12.83	9.95	7.68
Price to Earnings (P/E)	115.55	114.85	98.23	73.75	86.91	107.08	97.94	143.80	119.23	80.37	78.76
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.87%	0.87%	1.02%	1.36%	1.15%	0.93%	1.02%	0.70%	0.84%	1.24%	1.27%
Enterprise Value to Invested Capital (EV/IC)	21.07	25.26	22.91	17.71	19.46	24.23	18.24	18.64	24.26	22.04	14.62
Enterprise Value to Revenue (EV/Rev)	16.87	20.49	14.55	11.42	13.16	11.50	9.53	10.06	12.48	9.56	7.30
Enterprise Value to EBITDA (EV/EBITDA)	105.61	108.47	79.25	63.05	85.35	133.67	89.71	105.69	140.48	52.78	115.63
Enterprise Value to EBIT (EV/EBIT)	127.28	123.70	92.34	69.25	93.70	156.13	102.21	123.24	171.94	59.14	179.19
Enterprise Value to NOPAT (EV/NOPAT)	1,101.81	737.46	292.76	165.19	152.20	102.24	94.05	106.41	207.61	163.07	213.71
Enterprise Value to Operating Cash Flow (EV/OCF)	83.43	104.49	94.74	76.65	96.30	94.83	77.54	86.79	117.96	48.23	66.75
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	253.99	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.79	0.29	0.32	0.35	0.37	0.42	0.44	0.47	0.48	0.53	0.00
Long-Term Debt to Equity	0.68	0.29	0.32	0.35	0.37	0.42	0.44	0.47	0.48	0.53	0.00
Financial Leverage	-0.33	-0.38	-0.45	-0.44	-0.44	-0.56	-0.53	-0.53	-0.55	-0.57	-0.59
Leverage Ratio	2.22	2.00	2.01	2.02	2.06	2.17	1.91	1.90	1.89	1.96	1.56
Compound Leverage Factor	2.28	2.14	2.33	2.51	2.19	2.79	2.24	1.06	2.46	3.03	1.01
Debt to Total Capital	43.98%	22.62%	24.45%	26.03%	27.16%	29.53%	30.78%	31.86%	32.47%	34.70%	0.00%
Short-Term Debt to Total Capital	6.11%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	37.87%	22.62%	24.45%	26.03%	27.16%	29.53%	30.78%	31.86%	32.47%	34.70%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	56.02%	77.38%	75.55%	73.97%	72.84%	70.47%	69.22%	68.14%	67.53%	65.30%	100.00%
Debt to EBITDA	5.64	1.73	1.91	2.07	2.62	5.04	4.34	5.20	5.95	3.13	0.00
Net Debt to EBITDA	-2.18	-1.62	-2.43	-2.32	-2.63	-6.52	-3.30	-3.64	-3.97	-2.12	0.00
Long-Term Debt to EBITDA	4.86	1.73	1.91	2.07	2.62	5.04	4.34	5.20	5.95	3.13	0.00
Debt to NOPAT	58.89	11.76	7.04	5.42	4.67	3.86	4.55	5.23	8.79	9.68	0.00
Net Debt to NOPAT	-22.71	-11.04	-8.98	-6.08	-4.69	-4.99	-3.46	-3.67	-5.86	-6.56	0.00
Long-Term Debt to NOPAT	50.70	11.76	7.04	5.42	4.67	3.86	4.55	5.23	8.79	9.68	0.00
Altman Z-Score	7.63	13.23	10.43	8.30	8.91	7.55	6.26	6.37	7.30	5.55	7.54
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.83	2.30	2.96	2.88	2.91	3.14	3.15	3.38	3.33	3.00	2.79
Quick Ratio	2.22	1.54	2.03	1.91	2.03	2.28	2.28	2.41	2.39	2.21	1.84
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-652	-972	-446	-404	-467	-182	-183	-199	-150	-6.20	-86
Operating Cash Flow to CapEx	103.75%	1,008.69%	344.97%	731.25%	-98.63%	583.22%	450.06%	324.78%	-661.61%	1,131.91%	287.31%
Free Cash Flow to Firm to Interest Expense	-83.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.53	0.53	0.53	0.51	0.50	0.56	0.55	0.53	0.52	0.59
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	3.19	3.14	2.95	2.76	2.72	2.56	2.62	2.63	2.92	2.96	3.10
Fixed Asset Turnover	9.49	9.30	9.18	9.18	8.81	8.43	8.36	8.10	7.92	7.70	7.31
Accounts Payable Turnover	9.77	12.21	9.47	8.22	9.05	9.62	8.11	7.94	8.66	10.01	10.65
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	114.55	116.11	123.85	132.31	133.95	142.42	139.05	139.03	125.09	123.17	117.59
Days Payable Outstanding (DPO)	37.37	29.90	38.53	44.41	40.35	37.92	45.02	46.00	42.14	36.47	34.27
Cash Conversion Cycle (CCC)	77.18	86.21	85.32	87.90	93.61	104.50	94.04	93.04	82.96	86.70	83.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,782	1,689	1,233	1,168	1,137	741	767	737	657	515	535
Invested Capital Turnover	1.53	1.71	1.94	1.90	1.87	2.49	2.25	2.19	2.23	2.36	2.22
Increase / (Decrease) in Invested Capital	645	948	467	430	480	226	232	228	168	25	104
Enterprise Value (EV)	37,548	42,665	28,249	20,678	22,116	17,947	13,985	13,743	15,933	11,352	7,821
Market Capitalization	38,322	43,303	29,116	21,439	22,797	18,822	14,499	14,217	16,383	11,808	8,227
Book Value per Share	$33.36	$30.52	$27.79	$25.56	$24.13	$21.56	$20.35	$19.56	$19.26	$17.82	$17.32
Tangible Book Value per Share	$21.29	$18.30	$22.62	$20.35	$18.85	$20.53	$19.31	$18.48	$18.48	$17.02	$16.51
Total Capital	4,563	3,008	2,779	2,608	2,496	2,293	2,197	2,121	2,078	1,942	1,231
Total Debt	2,007	680	679	679	678	677	676	676	675	674	0.00
Total Long-Term Debt	1,728	680	679	679	678	677	676	676	675	674	0.00
Net Debt	-774	-639	-867	-761	-681	-875	-514	-474	-450	-457	-406
Capital Expenditures (CapEx)	25	25	26	11	16	24	14	13	8.51	12	14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	352	314	452	363	380	312	349	353	343	228	397
Debt-free Net Working Capital (DFNWC)	2,719	1,300	1,611	1,440	1,444	1,632	1,540	1,487	1,437	1,203	774
Net Working Capital (NWC)	2,440	1,300	1,611	1,440	1,444	1,632	1,540	1,487	1,437	1,203	774
Net Nonoperating Expense (NNE)	-95	-159	-47	-14	-120	-13	-12	16	-27	-10	6.54
Net Nonoperating Obligations (NNO)	-774	-639	-867	-761	-681	-875	-755	-708	-746	-753	-696
Total Depreciation and Amortization (D&A)	19	18	6.18	10	7.36	6.47	-1.33	4.11	3.56	4.95	5.84
Debt-free, Cash-free Net Working Capital to Revenue	15.80%	15.06%	23.29%	20.06%	22.63%	19.96%	23.82%	25.88%	26.89%	19.20%	37.01%
Debt-free Net Working Capital to Revenue	122.13%	62.42%	82.95%	79.51%	85.91%	104.58%	104.97%	108.92%	112.54%	101.30%	72.26%
Net Working Capital to Revenue	109.60%	62.42%	82.95%	79.51%	85.91%	104.58%	104.97%	108.92%	112.54%	101.30%	72.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.14	$1.78	$0.89	$0.54	$1.77	$0.76	$0.79	$0.17	$0.62	$0.41	$0.17
Adjusted Weighted Average Basic Shares Outstanding	76.89M	75.75M	75.70M	75.51M	75.36M	74.20M	74.83M	74.22M	72.64M	71.09M	71.11M
Adjusted Diluted Earnings per Share	$1.08	$1.68	$0.86	$0.53	$1.73	$0.75	$0.78	$0.16	$0.61	$0.39	$0.17
Adjusted Weighted Average Diluted Shares Outstanding	81.48M	78.56M	78.08M	77.55M	77.13M	75.46M	75.95M	75.78M	73.88M	72.53M	72.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	77.85M	76.62M	76.25M	75.57M	75.47M	75.30M	74.93M	74.76M	73.89M	72.86M	71.17M
Normalized Net Operating Profit after Tax (NOPAT)	-7.14	-10	20	27	13	30	49	28	12	19	19
Normalized NOPAT Margin	-1.18%	-1.79%	3.73%	5.26%	2.84%	6.93%	11.88%	7.52%	3.39%	5.61%	5.99%
Pre Tax Income Margin	17.96%	14.93%	14.62%	10.04%	35.97%	12.93%	17.36%	-3.23%	12.21%	10.33%	6.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	13.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-4.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Axon Enterprise's Financials

When does Axon Enterprise's fiscal year end?

According to the most recent income statement we have on file, Axon Enterprise's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Axon Enterprise's net income changed over the last 9 years?

Axon Enterprise's net income appears to be on an upward trend, with a most recent value of $377.03 million in 2024, rising from $19.93 million in 2015. The previous period was $175.78 million in 2023.

What is Axon Enterprise's operating income?

Axon Enterprise's total operating income in 2024 was $58.54 million, based on the following breakdown:

Total Gross Profit: $1.24 billion
Total Operating Expenses: $1.18 billion

How has Axon Enterprise revenue changed over the last 9 years?

Over the last 9 years, Axon Enterprise's total revenue changed from $197.89 million in 2015 to $2.08 billion in 2024, a change of 952.4%.

How much debt does Axon Enterprise have?

Axon Enterprise's total liabilities were at $2.15 billion at the end of 2024, a 19.7% increase from 2023, and a 2,846.0% increase since 2015.

How much cash does Axon Enterprise have?

In the past 9 years, Axon Enterprise's cash and equivalents has ranged from $40.65 million in 2016 to $598.55 million in 2023, and is currently $454.84 million as of their latest financial filing in 2024.

How has Axon Enterprise's book value per share changed over the last 9 years?

Over the last 9 years, Axon Enterprise's book value per share changed from 2.93 in 2015 to 30.52 in 2024, a change of 942.9%.

This page (LON:AXON) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Axon Enterprise (AXON) Financials

Frequently Asked Questions About Axon Enterprise's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Axon Enterprise (AXON) Financials

Annual Income Statements for Axon Enterprise

Quarterly Income Statements for Axon Enterprise

Annual Cash Flow Statements for Axon Enterprise

Quarterly Cash Flow Statements for Axon Enterprise

Annual Balance Sheets for Axon Enterprise

Quarterly Balance Sheets for Axon Enterprise

Annual Metrics And Ratios for Axon Enterprise

Quarterly Metrics And Ratios for Axon Enterprise

Frequently Asked Questions About Axon Enterprise's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools